Alejandro
Martín García Sancho
Profesor Asociado CC. Salud
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublications en collaboration avec des chercheurs de University of Texas MD Anderson Cancer Center (5)
2023
-
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma
Blood Advances, Vol. 7, Núm. 22, pp. 7141-7150
-
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma
Journal of Clinical Oncology
2022
2020
-
New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO)
British Journal of Haematology, Vol. 188, Núm. 6, pp. 888-897
2018
-
Rituximab plus lenalidomide in advanced untreated follicular lymphoma
New England Journal of Medicine, Vol. 379, Núm. 10, pp. 934-946